[Intravenous infusion of molsidomine in infarct therapy].
Zentgraf
B
B
Krankenanstalten Düren, Akademisches Lehrkankenhaus, RWTH Aachen.
Costard-Jäckle
A
A
Fuchs
M
M
Funke
K
K
Kreymann
G
G
Lessmann
J
J
Nowak
F G
FG
Milstrey
H R
HR
Schmidt
E G
EG
Simon
H
H
D000368:Aged; D000369:Aged, 80 and over; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005080:Exercise Test / Q000187:drug effects; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D008981:Molsidomine / Q000008:administration & dosage* / Q000009:adverse effects; D009203:Myocardial Infarction / Q000188:drug therapy*
D008981:Molsidomine
Die intravenöse Infusion von Molsidomin in der Infarkttherapie.